Group 1 - The establishment of the Zhongke Medical Valley, a comprehensive service platform for medical innovation, marks a significant breakthrough in the collaborative innovation ecosystem in Anhui Province, integrating government, medical, industrial, academic, research, and investment sectors [1] - The platform focuses on the medical device industry and aims to create a full-chain technology transfer platform that includes technology docking, consulting, professional training, concept verification, achievement roadshows, technology transfer, application scenarios, enterprise incubation, and investment financing [1] - The future goal of the platform is to incubate influential "Anhui Intelligent Manufacturing" healthcare products and build a medical technology innovation industry cluster [1]

Core Insights - The forum "Clinical Transformation and Financial Empowerment" was held in Shanghai, focusing on the bottlenecks in the transformation of medical technology achievements [1] - The forum introduced a pioneering trust company model for intellectual property services and launched the Shanghai Clinical Transformation Seed Investment Fund with an initial scale of 180 million RMB [1][2] - These initiatives signify significant progress in building a systematic and mechanized ecosystem for clinical achievement transformation in Shanghai, aiming to enhance medical innovation [1] Investment Fund Details - The Shanghai Clinical Transformation Seed Investment Fund was established to address the funding gap faced by early clinical innovation projects, often referred to as the "valley of death" [2] - The fund, with an initial scale of 180 million RMB, focuses on early and small investments, collaborating with clinical medical staff to navigate the transformation challenges [2] - The fund will prioritize high-growth potential areas such as innovative medical devices, innovative drugs, cell therapy, and nuclear medicine, aiming to discover and cultivate significant IP in the medical clinical field [2]

临转院董事长王兴鹏教授在致辞中表示，临转院自成立以来，始终致力于解决医疗科技成果转化过程中的痛点、难点问题，重点围绕"机制创新、金融 赋能、生态共建"三个维度发力，取得显著成效。 8月2日，由上海申康医院发展中心（以下简称"申康中心）指导，上海临床创新转化研究院（以下简称"临转院"）主办，上海研究型医院学会、上海国 有资本投资有限公司、上海临港经济发展集团有限公司、上海银行股份有限公司和上海国际信托有限公司协办的"临床转化、金融赋能"——上海临床成果转 移转化生态协同发展论坛暨"国投孚腾杯"临床创新创业大赛启动仪式在上海成功举行。 本次论坛聚焦医疗科技成果转化瓶颈，发布了全国首创的知识产权服务信托公司化运营模式及首个专注临床转化的上海临床转化种子投资基金，首关规 模为1.8亿元。同时，论坛启动了"国投孚腾杯"临床创新创业大赛，并发布了"临转科创汇"一站式医疗成果转移转化服务站，为临床科研成果的高效、高质 量转化提供全方位支撑。 临床创新创业大赛启动 在论坛上，临转院、孚腾资本、上海银行、浦东新区卫健委、浦东知识产权局等多家单位代表还共同启动了"国投孚腾杯"临床创新创业大赛。大赛将成 为筛选、孵化和投资潜力项目 ...

Group 1 - The forum focused on the bottlenecks in the transformation of medical technology achievements and introduced a novel trust company operation model for intellectual property services [1][2] - The Shanghai Clinical Transformation Research Institute launched a seed investment fund aimed at addressing the significant funding gap faced by early clinical innovation projects, with an initial scale of 180 million RMB [1][2] - The newly established investment fund emphasizes early and small investments, aiming to create a comprehensive support system for the transformation of scientific and technological achievements [1] Group 2 - The forum was guided by the Shanghai Shenkang Hospital Development Center and marked significant progress in building a systematic and mechanized ecosystem for clinical achievement transformation in Shanghai [2] - The event also initiated the "Guotou Futen Cup" Clinical Innovation Entrepreneurship Competition and launched the "Linzhuan Science and Technology Exchange" service station for efficient and high-quality transformation of clinical research achievements [2]